enGene Holdings Inc. Common Stock Analysis
| Analyst Ratings |
|
Average Target Price
|
35.50
|
|
Average Rating
|
4.63
|
|
# Strong Buys
|
5
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-07-31
|
-0.37
|
-0.32
|
0.05
|
13.51%
|
|
2024-06-30
|
-0.26
|
-0.38
|
-0.12
|
-46.15%
|
|
2024-04-30
|
-0.27
|
-0.38
|
-0.11
|
-41.42%
|
|
2024-03-31
|
0.00
|
-0.38
|
0.00
|
0.00%
|
|
2024-01-31
|
-0.47
|
-0.46
|
0.01
|
1.77%
|
|
2023-12-31
|
0.00
|
-0.46
|
0.00
|
0.00%
|
|
2023-10-31
|
0.00
|
-4.51
|
0.00
|
0.00%
|
|
2023-09-30
|
0.00
|
-4.51
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-07-31
|
-2.38
|
|
2023-10-31
|
-4.51
|
|
2023-09-30
|
-4.69
|
|
2022-10-31
|
0.04
|
|
2022-09-30
|
-0.07
|